411 related articles for article (PubMed ID: 16024878)
1. Neurodegenerative disorders: Parkinson's disease and Huntington's disease.
Hague SM; Klaffke S; Bandmann O
J Neurol Neurosurg Psychiatry; 2005 Aug; 76(8):1058-63. PubMed ID: 16024878
[TBL] [Abstract][Full Text] [Related]
2. The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases.
Ross CA; Pickart CM
Trends Cell Biol; 2004 Dec; 14(12):703-11. PubMed ID: 15564047
[TBL] [Abstract][Full Text] [Related]
3. [The role of alleles with an intermediate number of trinucleotide repeats in Parkinson's disease and other neurodegenerative disorders].
Nikitina MA; Bragina EY; Nazarenko MS; Alifirova VM
Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(7):42-50. PubMed ID: 35904291
[TBL] [Abstract][Full Text] [Related]
4. Normal CAG and CCG repeats in the Huntington's disease genes of Parkinson's disease patients.
Rubinsztein DC; Leggo J; Goodburn S; Barton DE; Ferguson-Smith MA
Am J Med Genet; 1995 Apr; 60(2):109-10. PubMed ID: 7485243
[TBL] [Abstract][Full Text] [Related]
5. Analysis of polyglutamine-coding repeats in the TATA-binding protein in different neurodegenerative diseases.
Wu YR; Fung HC; Lee-Chen GJ; Gwinn-Hardy K; Ro LS; Chen ST; Hsieh-Li HM; Lin HY; Lin CY; Li SN; Chen CM
J Neural Transm (Vienna); 2005 Apr; 112(4):539-46. PubMed ID: 15365789
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin-proteasome system and Parkinson's diseases.
Betarbet R; Sherer TB; Greenamyre JT
Exp Neurol; 2005 Feb; 191 Suppl 1():S17-27. PubMed ID: 15629758
[TBL] [Abstract][Full Text] [Related]
7. Genetic classification of primary neurodegenerative disease.
Hardy J; Gwinn-Hardy K
Science; 1998 Nov; 282(5391):1075-9. PubMed ID: 9804538
[TBL] [Abstract][Full Text] [Related]
8. Aggregopathy in neurodegenerative diseases: mechanisms and therapeutic implication.
Dohm CP; Kermer P; Bähr M
Neurodegener Dis; 2008; 5(6):321-38. PubMed ID: 18309232
[TBL] [Abstract][Full Text] [Related]
9. Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease?
Goldberg MS; Lansbury PT
Nat Cell Biol; 2000 Jul; 2(7):E115-9. PubMed ID: 10878819
[TBL] [Abstract][Full Text] [Related]
10. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
Ciechanover A; Kwon YT
Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
[TBL] [Abstract][Full Text] [Related]
11. The role of ubiquitin C-terminal hydrolase L1 in neurodegenerative disorders.
Gong B; Leznik E
Drug News Perspect; 2007; 20(6):365-70. PubMed ID: 17925890
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological promotion of inclusion formation: a therapeutic approach for Huntington's and Parkinson's diseases.
Bodner RA; Outeiro TF; Altmann S; Maxwell MM; Cho SH; Hyman BT; McLean PJ; Young AB; Housman DE; Kazantsev AG
Proc Natl Acad Sci U S A; 2006 Mar; 103(11):4246-51. PubMed ID: 16537516
[TBL] [Abstract][Full Text] [Related]
13. Protein misfolding in neurodegenerative diseases.
Agorogiannis EI; Agorogiannis GI; Papadimitriou A; Hadjigeorgiou GM
Neuropathol Appl Neurobiol; 2004 Jun; 30(3):215-24. PubMed ID: 15175075
[TBL] [Abstract][Full Text] [Related]
14. New aspects of genetic contributions to Parkinson's disease.
Hofer A; Gasser T
J Mol Neurosci; 2004; 24(3):417-24. PubMed ID: 15655263
[TBL] [Abstract][Full Text] [Related]
15. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of simple and choice reaction time in Parkinson's, Huntington's and cerebellar disease.
Jahanshahi M; Brown RG; Marsden CD
J Neurol Neurosurg Psychiatry; 1993 Nov; 56(11):1169-77. PubMed ID: 8229028
[TBL] [Abstract][Full Text] [Related]
17. Genetics of movement disorders: an abbreviated overview.
Thyagarajan D
Stereotact Funct Neurosurg; 2001; 77(1-4):48-60. PubMed ID: 12378057
[TBL] [Abstract][Full Text] [Related]
18. New movement in Parkinson's.
Lozano AM; Kalia SK
Sci Am; 2005 Jul; 293(1):68-75. PubMed ID: 16008304
[No Abstract] [Full Text] [Related]
19. [Genetics of prevalent neurodegenerative disorders].
Lladó A; Gaig C; Molinuevo JL
Med Clin (Barc); 2006 May; 126(17):662-70. PubMed ID: 16759568
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of neurodegenerative disease: role of the ubiquitin proteasome system.
Petrucelli L; Dawson TM
Ann Med; 2004; 36(4):315-20. PubMed ID: 15224658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
